Posted in | News | Quantum Computing

Archer Materials Australian Patent Granted for 12CQ Quantum Computing Chip

Archer Materials Limited (“Archer”, the “Company”) is pleased to announce the granting of the Australian Patent associated with Archer’s 12CQ quantum computing chip technology (“12CQ chip”). Archer is the only ASX listed company and one of a few players in the world developing qubit processor chip technology in the semiconductor industry.

Mohammad Choucair. Image Credit: Archer Materials Limited

The granting of the Australian Patent (Patent No. 2016363118) represents a significant earlystage milestone in Archer’s development of the 12CQ chip. The granted patent protects a proposed qubit processor chip that offers a path to realise practical quantum computing.

TheAustralian patent provides Archer with exclusive and legally enforceable commercial rights to the 12CQ chip invention in Australia. The protection provided by the Australian patent system gives Archer the right to stop others from manufacturing, using and/or selling the 12CQ chip technology invention in Australia, and is required for any possible future Australian commercialisation operations.

Commenting on the grant of the Australian patent, Archer CEO Dr Mohammad Choucair said: “We are excited about the grant of the 12CQ chip Australian patent. Patent protection in major markets is a central element in Archer’s strategy to develop the 12CQ chip. 

“Obtaining Australian patent approval effectively protects the 12CQ chip technology and prevents others from copying, making, or selling our devices in Australia.

“With the focus on quantum technologies in Australia now stronger than ever, we believe that the granting of the Australian patent related to Archer’s 12CQ chip will contribute to strengthening quantum computing and technology innovation in Australia.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.